Cargando…

The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19

AIMS: The immune response is essential for the control and resolution of viral infections. Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies were applied to modulate the immune responses of the affected patients. In this review, we aimed to describe the role of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansourabadi, Amir Hossein, Sadeghalvad, Mona, Mohammadi-Motlagh, Hamid-Reza, Rezaei, Nima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395832/ https://www.ncbi.nlm.nih.gov/pubmed/32750438 http://dx.doi.org/10.1016/j.lfs.2020.118185

Ejemplares similares

Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
por: Omidian, Neda, et al.
Publicado: (2022)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV
por: Hemmat, Nima, et al.
Publicado: (2021)

SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
por: Zarandi, Peyman Kheirandish, et al.
Publicado: (2021)

SARS‐CoV‐2 Omicron variant: Why global communities should take it seriously?
por: Rahmani, Shayan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!
por: Rahmani, Shayan, et al.
Publicado: (2022)

The role of SARS-CoV-2 accessory proteins in immune evasion
por: Zandi, Milad, et al.
Publicado: (2022)

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
por: Taefehshokr, Nima, et al.
Publicado: (2020)

Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials
por: Oroojalian, Fatemeh, et al.
Publicado: (2020)

A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines
por: Abdolmaleki, Gelareh, et al.
Publicado: (2022)

SARS-CoV-2 and Subacute Thyroiditis: A Case Report and Literature Review
por: Salehi, Amir Mohammad, et al.
Publicado: (2022)

Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections
por: Fani, Mona, et al.
Publicado: (2020)

CAR Macrophages for SARS-CoV-2 Immunotherapy
por: Fu, Wenyan, et al.
Publicado: (2021)

Current understanding of T cell immunity against SARS-CoV-2
por: Lu, Xiuyuan, et al.
Publicado: (2022)

The role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types
por: Samimi, Nastaran, et al.
Publicado: (2021)

Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy
por: Fani, Mona, et al.
Publicado: (2023)

Air Surveillance for Viral Contamination with SARS-CoV-2 RNA at a Healthcare Facility
por: Zahedi, Amir, et al.
Publicado: (2022)

Current status of therapeutic approaches and vaccines for SARS-CoV-2
por: Wahid, Braira, et al.
Publicado: (2021)

Facing SARS-CoV-2 outbreak in immunotherapy era
por: Citarella, Fabrizio, et al.
Publicado: (2020)

A novel X-linked mutation in IL2RG associated with early-onset inflammatory bowel disease: a case report of twin brothers
por: Rayzan, Elham, et al.
Publicado: (2023)

Dynamics of host immune responses to SARS-CoV-2
por: Taherkhani, Reza, et al.
Publicado: (2021)

The immune response and immune evasion characteristics in SARS-CoV, MERS-CoV, and SARS-CoV-2: Vaccine design strategies
por: Molaei, Soheila, et al.
Publicado: (2021)

Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency
por: Delavari, Samaneh, et al.
Publicado: (2020)

SARS-CoV-2 detection in hospital indoor environments, NW Iran
por: Mohammadi, Amir, et al.
Publicado: (2022)

β Cell and Autophagy: What Do We Know?
por: Mohammadi-Motlagh, Hamid-Reza, et al.
Publicado: (2023)

Immune Responses in SARS-CoV-2, SARS-CoV, and MERS-CoV Infections: A Comparative Review
por: Irani, Soussan
Publicado: (2022)

Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic
por: Singh, Shalinder, et al.
Publicado: (2020)

Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy
por: Cheng, Zhangkai J., et al.
Publicado: (2022)

Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
por: Piening, Alexander, et al.
Publicado: (2022)

The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
por: Boechat, J.L., et al.
Publicado: (2021)

Immune response to SARS‐CoV‐2 in children: A review of the current knowledge
por: Filippatos, Filippos, et al.
Publicado: (2021)

Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives
por: Zhu, Qiugang, et al.
Publicado: (2022)

Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
por: Zhou, Dongyan, et al.
Publicado: (2021)

SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants
por: Panikkar, Archana, et al.
Publicado: (2022)

Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2
por: Yao, Zhixian, et al.
Publicado: (2020)

Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Li, Jin-Yan, et al.
Publicado: (2021)

The first detection of SARS-CoV-2 RNA in the wastewater of Tehran, Iran
por: Tanhaei, Mohammad, et al.
Publicado: (2021)

Binder design for targeting SARS-CoV-2 spike protein: An in silico perspective
por: Etemadi, Ali, et al.
Publicado: (2022)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nhs58mu10ntpkp616ln38e6a12